Heilent Pharmaceuticals Private Limited
About Heilent Pharmaceuticals Private Limited
Data last updated:
Heilent Pharmaceuticals Private Limited is a private limited company based in Sulthan Bathery, Kerala, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 17 August 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Ernakulam, under CIN U24110KL2016PTC046570. Its GSTIN is 32AADCH9504Q1Z9 (Kerala).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹2 Lakh. It is led by directors Sidheeque Ullattil (Managing Director) and Jaseera.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at No.1303 W No.11 Sulthan Bathery Post, Kerala, India – 673592.
As per the financials filed for FY 2025, the company reported a revenue of ₹32.7 Lakh, a decline of 16% compared to the previous year. For the same year it recorded a net profit of ₹34,924 (net margin 1.1%) and EBITDA of ₹56,876 (EBITDA margin 1.7%). Revenue has declined at a compounded annual rate (CAGR) of 21% over three years and 10% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Heilent Pharmaceuticals Private Limited's registered office is in Sulthan Bathery, Kerala. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressNo.1303 W No.11 Sulthan Bathery Post, Kerala, India – 673592
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Heilent Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Heilent Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Heilent Pharmaceuticals Private Limited, buy the company report.
Financials of Heilent Pharmaceuticals Private Limited
FY 2025 filings availableHeilent Pharmaceuticals Private Limited reported revenue of ₹32.7 Lakh (down 16% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 10% over five years, including a 16% fall in the latest year. EBITDA rose 15% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹56,876 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹34,924 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.7% | ||||
| Net Profit Margin | 1.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Heilent Pharmaceuticals Private Limited, buy the company report.
Board of directors of Heilent Pharmaceuticals Private Limited
Heilent Pharmaceuticals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Jaseera | Director | 17 Aug 2016 | 10 Years 2 Months | Current |
| Sidheeque Ullattil | Managing Director | 17 Aug 2016 | 10 Years 2 Months | Current |
Peer comparison
Heilent Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Etico Research Private Limited | ₹32.77 Lakh (FY 2024) | Hyderabad, Telangana, India | ||||
| Heilent Pharmaceuticals Private Limitedthis company | ₹32.7 Lakh (FY 2025) | ₹34,924 | 1.1% | -16.0% | Sulthan Bathery, Kerala, India | |
| Aurixa Pharmaceuticals Private Limited | ₹32.69 Lakh (FY 2025) | -5.0% | Raigad, Maharashtra, India | |||
| Aadmex Lifesciences Private Limited | ₹32.67 Lakh (FY 2025) | -22.0% | Ahmedabad, Gujarat, India |
To see the full peer comparison of Heilent Pharmaceuticals Private Limited, buy the company report.
Auditor
Heilent Pharmaceuticals Private Limited is audited by THOMAS C S & ASSOCIATES for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| THOMAS C S & ASSOCIATES | FY 2017 | 012230S |
Shareholding
The shareholding of Heilent Pharmaceuticals Private Limited is on record for FY 2017, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2017 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Public | |
| Others |
To see the full shareholding pattern of Heilent Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Heilent Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Heilent Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Heilent Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 32AADCH9504Q1Z9 | Kerala | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Heilent Pharmaceuticals Private Limited, buy the company report.
Recent activity
Heilent Pharmaceuticals Private Limited has 4 board changes on record since 2016: 2 appointments and 2 cessations. The latest: Kulakkunnathu Sajeesh Kumar ceased to be Director on 29 Aug 2022.
Frequently asked questions
Heilent Pharmaceuticals is an active private limited company based in Sulthan Bathery, Kerala, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 17 August 2016 (10+ years old) and is registered under CIN U24110KL2016PTC046570.
Heilent Pharmaceuticals has 2 current directors:
- Sidheeque Ullattil - Managing Director
- Jaseera - Director
The latest financial statements of Heilent Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Heilent Pharmaceuticals is 32AADCH9504Q1Z9, registered in Kerala.
The CIN (Corporate Identification Number) of Heilent Pharmaceuticals is U24110KL2016PTC046570. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Heilent Pharmaceuticals was incorporated on 17 August 2016, making it 10+ years old. It is registered with the Registrar of Companies, Ernakulam.
The peers of Heilent Pharmaceuticals by revenue are Etico Research Private Limited, Aurixa Pharmaceuticals Private Limited, Aadmex Lifesciences Private Limited, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading).
Kulakkunnathu Sajeesh Kumar ceased to be Director on 29 Aug 2022. Sanish Putharitharayil Damodharan ceased to be Director on 12 Feb 2022. Jaseera was appointed as Director on 17 Aug 2016. Heilent Pharmaceuticals has 4 board changes on record in total.
The registered office of Heilent Pharmaceuticals is at No.1303 W No.11 Sulthan Bathery Post, Kerala, India – 673592.
Heilent Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
The compliance status of Heilent Pharmaceuticals is compliant as of 07 September 2026. The company is actively filing with the Registrar of Companies.